Trial intelligence / Profile preview

Bleomycin vs 5-fluorouracil for Plantar Warts

NCT05057663Unknown

Sponsor
Sohag University
Start
Nov 2021
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial in plantar wart comparing Bleomycin group with 5-Fluorouracil group (2 arms). Primary endpoint: Response to intralesional injection of bleomycin, 5fluorouracil in treatment of plantar wart at 3 months. Status: unknown.

02

Drugs

bleomycinfluorouracil
03

Conditions

plantar wart

Beyond the preview

Go deeper on NCT05057663.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05057663.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call